First Half of 2024: RHÖN-KLINIKUM AG Continues Good Business Performance – Outlook Confirmed

RHÖN-KLINIKUM AG has recorded a 6.5% increase in revenues, totaling 775.5 million euros for the first half of 2024. Consolidated profit surged by 68.9% to 20.6 million euros, despite a challenging market environment. The company treated 463,111 patients, an increase of 3.8% compared to the same period in the previous year.

EBITDA reached 49.1 million euros, surpassing the previous year's 45.2 million euros. However, costs for materials and consumables rose due to higher purchasing prices and the provision of cost-intensive services, reaching 266.2 million euros.

The outlook for 2024 expects revenues to be around 1.6 billion euros, with EBITDA projected between 110 million and 120 million euros. The forecast includes uncertainties due to global inflation, price increases, and regulatory measures affecting remuneration structures.

RHÖN-KLINIKUM AG's five hospital sites in Bavaria, Brandenburg, Hesse, and Thuringia continue to demonstrate solid performance, positioning the company well for the forthcoming healthcare reform, according to Prof Dr. Tobias Kaltenbach, Chairman of the Board of Management.